Histogenics - 48 Year Dividend Yield History | HSGX

Historical dividend payout and yield for Histogenics (HSGX) since 1971. The current TTM dividend payout for Histogenics (HSGX) as of February 15, 2019 is $0.00. The current dividend yield for Histogenics as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.008B $0.000B
Histogenics Corporation is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment. The company is developing NeoCart(R) product to provide treatment in the orthopedic space. Histogenics Corporation is headquartered in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76